Covid-19: Pakistan approves China's Sinovac vaccine for emergency use

Islamabad - It is the third Chinese Covid-19 vaccine to be approved by the country after Sinopharm and CanSino vaccines.

Amid the ongoing third wave of the Covid-19 pandemic, the Drug Regulatory Authority of Pakistan (DRAP) has approved China's Sinovac vaccine against the virus for emergency use, the National Institute of Health in Islamabad announced.

According to a statement released by DRAP, the CoronaVac vaccine developed by Chinese pharmaceutical company Sinovac has been given emergency use authorisation for people aged 18 and above, Xinhua news agency reported.

The statement said the authorisation will be reviewed every quarter keeping in view data regarding safety, efficacy and quality of the vaccine.